PFBT
FLGT icon

Parkside Financial Bank & Trust’s Fulgent Genetics FLGT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26
Closed -$684 – 2725
2025
Q4 		$684 Hold
26
– – ﹤0.01% 2479
2025
Q3 		$588 Buy
+26
New +$535 ﹤0.01% 2492
2024
Q4 		– Sell
-9
Closed -$196 – 2152
2024
Q3 		$196 Hold
9
– – ﹤0.01% 2012
2024
Q2 		$177 Buy
+9
New +$188 ﹤0.01% 1964
2023
Q4 		– Sell
-141
Closed -$3.77K – 2099
2023
Q3 		$3.77K Sell
141
-88
-38% -$3K ﹤0.01% 1467
2023
Q2 		$8.48K Hold
229
– – ﹤0.01% 1177
2023
Q1 		$7.15K Buy
229
+124
+118% +$3.99K ﹤0.01% 1224
2022
Q4 		$3.13K Sell
105
-3
-3% -$107 ﹤0.01% 1519
2022
Q3 		$4K Sell
108
-38
-26% -$1.91K ﹤0.01% 1294
2022
Q2 		$8K Sell
146
-4
-3% -$220 ﹤0.01% 1063
2022
Q1 		$9K Sell
150
-15
-9% -$988 ﹤0.01% 1064
2021
Q4 		$17K Buy
165
+110
+200% +$9.67K ﹤0.01% 858
2021
Q3 		$5K Buy
55
+16
+41% +$1.45K ﹤0.01% 1231
2021
Q2 		$4K Buy
39
+8
+26% +$639 ﹤0.01% 1310
2021
Q1 		$3K Buy
+31
New +$3.2K ﹤0.01% 1374

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parkside Financial Bank & Trust's FLGT Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 26 shares — an estimated $684 sold.

Parkside Financial Bank & Trust first reported a position in FLGT in Q1 2021 and held it in 15 quarters. The position peaked at $17K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 26 Fulgent Genetics shares in Q1 2026, an estimated $684.
  • Parkside Financial Bank & Trust first reported a position in Fulgent Genetics in Q1 2021 and held it in 15 quarters.
  • Parkside Financial Bank & Trust's Fulgent Genetics position peaked at $17K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.